For example, Takayama et al. studied the use of the serological tumour antigen regenerating islet-derived protein 4 (REG4) in 200 subjects, including patients with adenocarcinoma, intrapapillary mucinous tumours, patients with pancreatitis, and healthy controls. The gene discussed is REG4; the disease is adenocarcinoma.